Surgery Partners, Inc. (SGRY) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $13.22. It has a SharesGrow Score of 42/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of SGRY = $159.49 (+1106.4% from the current price, the stock appears undervalued). Analyst consensus target is SGRY = $19 (+42.6% upside).
Valuation: SGRY trades at a trailing Price-to-Earnings (P/E) of -20.7 (S&P 500 average ~25).
Financials: revenue is $3.3B, +9.3%/yr average growth. Net income is $78M (loss), growing at -393.6%/yr. Net profit margin is -2.4% (negative). Gross margin is 23.1% (+0.5 pp trend).
Balance sheet: total debt is $4.0B against $1.7B equity (Debt-to-Equity (D/E) ratio 2.35, leveraged). Current ratio is 1.87 (strong liquidity). Debt-to-assets is 48.8%. Total assets: $8.2B.
Analyst outlook: 14 / 22 analysts rate SGRY as buy (64%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 90/100 (Pass), Growth 40/100 (Partial), Past 0/100 (Fail), Health 33/100 (Fail), Moat 49/100 (Partial), Future 73/100 (Pass), Income 10/100 (Fail).
